Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.3.2, replacing the previous v3.3.1 entry.
    Difference
    0.0%
    Check dated 2025-12-01T16:43:39.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces v3.2.0 as an administrative update; no substantive changes to study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:20:43.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the funding-disclaimer banner about potential delays and outdated information. This is an administrative change that does not alter the study details, enrollment, or outcomes.
    Difference
    0.2%
    Check dated 2025-11-17T06:21:49.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details and eligibility criteria remain as published.
    Difference
    0.3%
    Check dated 2025-11-03T00:56:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T09:08:31.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page now announces Revision: v3.1.0 and removes several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), signaling a rebranding or scope reduction without adding new topics.
    Difference
    0.3%
    Check dated 2025-09-28T03:05:41.000Z thumbnail image

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.